Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125068223 | 12506822 | 3 | F | 2010 | 20160721 | 20160629 | 20160726 | EXP | US-ROCHE-1784121 | ROCHE | 0.00 | F | Y | 49.94000 | KG | 20160726 | MD | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125068223 | 12506822 | 1 | PS | CELLCEPT | MYCOPHENOLATE MOFETILMYCOPHENOLATE MOFETIL HYDROCHLORIDE | 1 | Unknown | Y | 50722 | ||||||||||
125068223 | 12506822 | 2 | C | PREDNISONE. | PREDNISONE | 1 | 0 | ||||||||||||
125068223 | 12506822 | 3 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | 0 | ||||||||||||
125068223 | 12506822 | 4 | C | PROTONIX | PANTOPRAZOLE SODIUM | 1 | 0 | ||||||||||||
125068223 | 12506822 | 5 | C | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | Unknown | 0 | 20 | MG | QD | ||||||||
125068223 | 12506822 | 6 | C | MIRTAZAPINE. | MIRTAZAPINE | 1 | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125068223 | 12506822 | 1 | Autoimmune hepatitis |
125068223 | 12506822 | 2 | Autoimmune hepatitis |
125068223 | 12506822 | 3 | Autoimmune thyroiditis |
125068223 | 12506822 | 4 | Gastrooesophageal reflux disease |
125068223 | 12506822 | 5 | Gastrooesophageal reflux disease |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125068223 | 12506822 | OT |
125068223 | 12506822 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125068223 | 12506822 | Acute respiratory distress syndrome | |
125068223 | 12506822 | Alopecia | |
125068223 | 12506822 | Asthenia | |
125068223 | 12506822 | Asthma | |
125068223 | 12506822 | Autoimmune hepatitis | |
125068223 | 12506822 | Chronic obstructive pulmonary disease | |
125068223 | 12506822 | Decreased appetite | |
125068223 | 12506822 | Drug ineffective | |
125068223 | 12506822 | Dyspepsia | |
125068223 | 12506822 | Hiatus hernia | |
125068223 | 12506822 | Hip fracture | |
125068223 | 12506822 | Lung abscess | |
125068223 | 12506822 | Malaise | |
125068223 | 12506822 | Plasma cell myeloma | |
125068223 | 12506822 | Pneumonia | |
125068223 | 12506822 | Pulmonary fibrosis | |
125068223 | 12506822 | Weight decreased | |
125068223 | 12506822 | White blood cell count increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125068223 | 12506822 | 1 | 2009 | 2010 | 0 |